A Comparison of Belatacept Conversion Regimens from Calcineurin Inhibitor-Based Immunosuppression
Association of Belatacept Conversion on Patient and Allograft Survival in Kidney Transplant Recipients with Congestive Heart Failure
Avoiding Tacrolimus Under- and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial
Belatacept Conversion in Elderly Renal Transplant Recipients
Belatacept Utilization During the Covid-19 Pandemic in the United States
Calcineurin Inhibitor Dose and Selection, Not Antiproliferatives or Steroids, Influence Development of DSA One Year Post-kidney Transplant
CD40 Blockade by the Fc-Silent Immunosuppressive Antibody Iscalimab Results in Diminished B Cell Activation and Differentiation and is Paralleled by Whole Blood Gene Expression Data
Conversion to Belatacept Based Immunosuppression Regimen in Kidney Transplant Patients: Lessons Learned
Early Conversion to Belatacept-based Therapy Improves Graft Function in Renal Transplant Patients
Effect of Early Steroid Withdrawal on Posttransplant Diabetes Mellitus Among Kidney Transplant Recipients Differs by Recipient Age
2021 American Transplant Congress